AP1G1 and amyloidosis: Surprisingly, SrfGFAPCKO; ADTg+/- mice greatly reduced number of plaques in the neocortex and hippocampus (Figure 6H, I), demonstrating that Srf-deficient astrocytes aid in efficient plaque reduction and that longer presence of these mutant astrocytes promoted greater reduction in amyloid plaques.